doi: 10.3389/fddev.2024.1456654 Received 28 June 2024 Accepted 14 October 2024 Published 06 November 2024 Volume 4 - 2024 Edited by Rakesh Patel, Shree S K Patel College of Pharmaceutical Education and Research Ganpat University, India Reviewed by Fiona McCartney, University College Dublin, Ireland Samar ISSA, cole de Biologie Industrielle, France Updates Copyright 2024 New, Bogus, Travers, Hahn, Vaiceliunaite, Burnet, Wang and Wen
A., El-Aal, S
People with type 1 diabetes lack insulin production and require insulin therapy for survival, while those with type 2 diabetes might use insulin when other medications are insufficient to control their blood glucose levels
16 In October 2024, Novo Nordisk entered a settlement with Natco Pharma and Mylan (a subsidiary of Viatris) in relation to its product Ozempic
The vial goes cloudy, the peptide aggregates, and the dose is non-functional